External preparation
A topical agent and selected technology, applied in the field of topical agents containing tranexamic acid, can solve the problems of easy precipitation of crystals and high crystallinity
Pending Publication Date: 2021-09-03
MARUZEN PHARMA
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0004] However, although tranexamic acid is water-soluble, on the other hand, there is a problem that the crystallinity is very high, and crystals are easily precipitated due to the evaporation of water.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0055] Examples and comparative examples are given below to specifically describe the present invention, but the present invention is not limited by the following examples. It should be noted that, in the following examples, unless otherwise specified, "%" in the composition means mass %, ratio means mass ratio, and the amounts of each component in the table are amounts converted from pure components.
[0056] For the following components, a tranexamic acid crystallization inhibition test was performed at the concentrations described in the table. Record the results together in the table.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
According to the present invention, an external preparation is configured to contain (A) one or more substances that are selected from among tranexamic acid, tranexamic acid derivatives and salts of tranexamic acid or tranexamic acid derivatives, and (B) one or more substances that are selected from among arginine, aspartic acid, glutamic acid, glycine, proline, serine, threonine, gamma-aminobutyric acid, derivatives of these compounds, and salts of these compounds or the derivatives of these compounds, thereby being capable of suppressing crystallization of tranexamic acid.
Description
technical field [0001] The present invention relates to external preparations containing tranexamic acid. [0002] Background of the invention [0003] Tranexamic acid has hemostatic and anti-inflammatory effects, and is widely used in toothpaste, pharmaceuticals, and the like. In addition, it has a rough skin-improving effect and a whitening effect, and is also used as an external preparation for skin or hair such as cosmetics. [0004] However, although tranexamic acid is water-soluble, on the other hand, there is a problem that crystallinity is very high and crystals are easily precipitated by evaporation of water. As a method for suppressing the crystallization of such tranexamic acid, combined use of phytic acid (Patent Document 1: JP-A No. 2018-48097) and polyhydroxy acid (Patent Document 2: JP-A No. 2013-121955) has been proposed. etc. method. However, a method with a further excellent effect of inhibiting the crystallization of tranexamic acid is desired. [0005]...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/195A61P7/04A61P29/00A61P17/00A61Q19/00A61Q5/00A61K9/08A61K8/44A61K47/18A61K47/22
CPCA61P17/00A61Q5/00A61P29/00A61K47/22A61Q19/00A61K8/44A61K31/195A61K47/18A61P7/04A61K9/08
Inventor 池田良岛家圭悟
Owner MARUZEN PHARMA



